Oncotelic Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 457.3M |
| FY2023 | 396.2M |
| FY2024 | 404.4M |
| FY2025 | 422.2M |
| FY2026 | 444.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 457.3M |
| FY2023 | 396.2M |
| FY2024 | 404.4M |
| FY2025 | 422.2M |
| FY2026 | 444.2M |